Effect of Laparoscopic Mini-Gastric Bypass for Type 2 Diabetes Mellitus: Comparison of BMI >35 and <35 kg/m2
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Laparoscopic gastric bypass resulted in significant weight loss and resolution of type 2 diabetes mellitus (T2DM). The current indication for bariatric surgery is mainly applied for patients with body mass index (BMI) >35 kg/m2 with comorbidity status. However, little is known concerning T2DM patients with BMI <35 kg/m2. Recent studies have suggested that T2DM patients with BMI <35 kg/m2 might benefit from gastric bypass surgery.
From Jan 2002 to Dec 2006, 820 patients who underwent laparoscopic mini-gastric bypass were enrolled in a surgically supervised weight loss program. We identified 201 (24.5%) patients who had impaired fasting glucose or T2DM. All the clinical data were prospectively collected and stored. Patients with BMI <35 kg/m2 were compared with those of BMI >35 kg/m2. Successful treatment of T2DM was defined by HbA1C <7.0%, LDL <100 mg/dl, and triglyceride <150 mg/dl.
Among the 201 patients, 44 (21.9%) had BMI <35 kg/m2, and 114 (56.7%) had BMI between 35and 45, 43 (21.4%) had BMI >45 kg/m2. Patients with BMI <35 kg/m2 are significantly older, female predominant, had lower liver enzyme and C-peptide levels than those with BMI >35 kg/m2. The mean total weight loss for the population was 32.1, 33.4, 31.9, and 32.8% (at 1, 2, 3, 5 years after surgery), and percentage to change in BMI was 31.9, 34.2, 32.2, and 29.5% at 1, 2, 3, and 5 years. One year after surgery, fasting plasma glucose returned to normal in 89.5% of BMI <35 kg/m2 T2DM and 98.5% of BMI >35 kg/m2 patients (p = 0.087). The treatment goal of T2DM (HbA1C <7.0%, LDL <150 mg/dl and triglyceride <150 mg/dl) was met in 76.5% of BMI <35 kg/m2 and 92.4% of BMI >350 kg/m2 (p = 0.059).
Laparoscopic gastric bypass resulted in significant and sustained weight loss with successful treatment of T2DM up to 87.1%. Despite a slightly lower response rate of T2DM treatment, patients with BMI <35 still had an acceptable DM resolution, and this treatment option can be offered to this group of patients.
- King H, Aubert RE, Herman WH. Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care 1998;21:1414–1431. CrossRef
- Zimmer P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001;414:782–787. CrossRef
- Diabetes Control and Complications Trial. The relationship of glycemic exposure (HbA sub1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial. Diabetes 1995;44:968–983. CrossRef
- UK Prospective Diabetes Study Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837–853. CrossRef
- UK Prospective Diabetes Study Group. Effect of intensive blood glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPD 34). Lancet 1998;352:854–865. CrossRef
- Pories WJ, Swanson MS, MacDonald KG, Long SB, Morris PG, Brown BM, Barakat HA, deRamon RA, Israel G, Dolezal JM, Dohm L. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 1995;222:339–352. CrossRef
- Dixon JB, O’Brien PE. Health outcomes of severely obese type 2 diabetes subjects 1 year after laparoscopic adjustable gastric banding. Diabetes Care 2002;25:358–363. CrossRef
- Sjostrom L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. New Engl J Med 2004;351:2683–2693. CrossRef
- Gumbs AA, Modlin IM, Ballantyne GH. Changed in insulin resistance following bariatric surgery: role of caloric restriction and weight loss. Obes Surg 2005;15:462–473. CrossRef
- Schauer PR, Burguera B, Ikramuddin S, Cottam D, Gourash W, Hamad G, Eid GM, Mattar S, Ramanathan R, Barinas-Mitchel E, Rao RH, Kuller L, Kelley D. Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg 2003;238:467–485.
- O’Brien PE, Dixon JB, Laurie C, Skinner S, Proietto J, McNeil J, Strauss B, Marks S, Schachter L, Chapman L, Anderson M. Treatment of mild to moderate obesity with laparoscopic adjustable gastric banding or an intensive medical program. Ann Intern Med 2006;144:625–633.
- Cohen R, Pinheiro JS, Correa JL, Schiavon C. Laparoscopic Roux-en-Y gastric bypass for BMI <35 kg/m2: a tailored approach. Surg Obes Related Disease 2006;2:401–404. CrossRef
- Lee WJ, Wang W. Bariatric surgery: Asia-pacific perspective. Obes Surg 2005;15:751–757. CrossRef
- Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003;26:S5–S20.
- Wang W, Wei PL, Lee YC, Huang MT, Chiu CC, Lee WJ. Short-term results of laparoscopic mini-gastric bypass. Obes Surg 2005;15:648–654. CrossRef
- Chen TC, Huang MT, Lee WJ, Wang W, Wei PL, Yu PJ. Laparoscopic Roux-en-Y versus mini-gastric bypass for the treatment of morbid obesity: a prospective randomized controlled clinical trial. Ann Surg 2005;242:20–28. CrossRef
- Lee WJ, Wang W, Yu PJ, Wei PL, Huang MT. Gastrointestinal quality of life following laparoscopic adjustable gastric banding in Asia. Obes Surg 2006;16:586–591. CrossRef
- Saydah SH, Fradkin J, Cowie CC. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA 2004;291:335–342. CrossRef
- Deurenberg P, Deurenberg-Yap M, van Staveren WA. Body mass index and percent body fat: a meta-analysis among different ethnic groups. Int J Obes 1998;22:1164–1171. CrossRef
- Jia WP, Lu JX, Xiang KS, Chen L, Lu J, Wu YM. Epidemiological study on obesity and its comorbidities in urban Chinese older than 20 years of age in Shanghai, China. Obes Rev 2002;3:157–165. CrossRef
- Hickey MS, Pories WJ, MacDonald KG, Cory KA, Dohm GL, Swanson MS, Israel RG, Barakat HA, Considine RV, Caro JF, Houmard JA. A new paradigm for type 2 diabetes mellitus. Could it be a disease of the foregut? Ann Surg 1998;227:637–644. CrossRef
- Greenway SE, Greenway EL, Klevin S. Effect of obesity surgery on non-insulin-dependent diabetes mellitus. Arch Surg 2002;137:1109–1117. CrossRef
- Rubino F, Marescaux J. Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease. Ann Surg 2004;239:1–11. CrossRef
- Rubino F, Gagner M, Gentileschi P, Kini S, Fukuyama S, Feng J, Diamond E. The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism. Ann Surg 2004;240:236–242. CrossRef
- Rubino F, Forgione A, Cummings D, Vix M, Gnuli D, Mingrone G, Castagneto M, Marescaux J. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg 2006;244:741–749. CrossRef
- Flum DR, Salem L, Elrod JAB, Dellinger EP, Cheadle A, Chan L. Early mortality among medicare beneficiaries undergoing bariatric surgical procedures. JAMA 2005;294:1903–1908. CrossRef
- Goldfeder LB, Ren CJ, Gill JR. Fatal complications of bariatric surgery. Obes Surg 2006;16:1050–1056. CrossRef
- Pratt GM, McLee B, Pories WJ. The ASBS bariatric surgery centers of excellence program: a blueprint for quality improvement. Surg Obes Relat Dis 2006;2:497–503. CrossRef
- Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Illane-Parikka P, Keinänen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M; Finnish Diabetes prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. NEJM 2001;344:1343–1350. CrossRef
- Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;393–403.
- Ash S, Reeves MM, Yeo S, Morrison G, Carey D, Capra S. Effect of intensive dietetic interventions on weight and glycaemic control in overweight men with type II diabetes: a randomized trial. Int J Obes 2003;27:797–802. CrossRef
- Harder H, Dinesen B, Astrup A. The effect of rapid weight loss on lipid profile and glycemic control in obese type 2 diabetic patients. Int J Obes 2004;28:180–182. CrossRef
- Standards of medical care in diabetes-2007. Diabetes Care 2007;30(Suppl 1):S4–S41.
- Collins R, Armitage J, Parish S, Sleight P, Peto R. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomized placebo-controlled trial. Lancet 2003;361:2005–2016. CrossRef
- Lee WJ, Huang MT, Wang W, Lin CM, Chen TC, Lai IR. Effects of obesity surgery on the metabolic syndrome. Arch Surg 2004;139:1088–1092. CrossRef
- Effect of Laparoscopic Mini-Gastric Bypass for Type 2 Diabetes Mellitus: Comparison of BMI >35 and <35 kg/m2
Journal of Gastrointestinal Surgery
Volume 12, Issue 5 , pp 945-952
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Type 2 DM
- Bariatric surgery
- BMI <35
- Industry Sectors
- Author Affiliations
- 1. Department of Surgery, Min-Sheng General Hospital, Taoyuan, Taiwan, Republic of China
- 4. Department of Surgery, Min-Sheng General Hospital, National Taiwan University, No. 168, Ching Kuo Road, Taoyuan, Taiwan, Republic of China
- 2. Department of Surgery, Taipei Medical University Hospital, Taipei, Taiwan, Republic of China
- 3. Department of International Business, Ching Yun University, Taoyuan, Taiwan